Pharmaceuticals in Singapore

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Scope

Essential resource for top-line data and analysis covering the Singapore pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons to buy

_x005F What was the size of the Singapore pharmaceuticals market by value in 2015

_x005F What will be the size of the Singapore pharmaceuticals market in 2020

_x005F What factors are affecting the strength of competition in the Singapore pharmaceuticals market

_x005F How has the market performed over the last five years

_x005F Who are the top competitors in Singapore's pharmaceuticals market

Companies mentioned

GlaxoSmithKline Plc

Novartis AG

Pfizer Inc.

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

GlaxoSmithKline Plc

Novartis AG

Pfizer Inc.

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

List of Tables

Table 1: Singapore pharmaceuticals market value: $ billion, 201115

Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2015

Table 3: Singapore pharmaceuticals market share: % share, by value, 2015

Table 4: Singapore pharmaceuticals market value forecast: $ billion, 201520

Table 5: GlaxoSmithKline Plc: key facts

Table 6: GlaxoSmithKline Plc: key financials ($)

Table 7: GlaxoSmithKline Plc: key financials (£)

Table 8: GlaxoSmithKline Plc: key financial ratios

Table 9: Novartis AG: key facts

Table 10: Novartis AG: key financials ($)

Table 11: Novartis AG: key financial ratios

Table 12: Pfizer Inc.: key facts

Table 13: Pfizer Inc.: key financials ($)

Table 14: Pfizer Inc.: key financial ratios

Table 15: Singapore size of population (million), 201115

Table 16: Singapore gdp (constant 2005 prices, $ billion), 201115

Table 17: Singapore gdp (current prices, $ billion), 201115

Table 18: Singapore inflation, 201115

Table 19: Singapore consumer price index (absolute), 201115

Table 20: Singapore exchange rate, 201115

List of Figures

Figure 1: Singapore pharmaceuticals market value: $ billion, 201115

Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 3: Singapore pharmaceuticals market share: % share, by value, 2015

Figure 4: Singapore pharmaceuticals market value forecast: $ billion, 201520

Figure 5: Forces driving competition in the pharmaceuticals market in Singapore, 2015

Figure 6: Drivers of buyer power in the pharmaceuticals market in Singapore, 2015

Figure 7: Drivers of supplier power in the pharmaceuticals market in Singapore, 2015

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2015

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2015

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2015

Figure 11: GlaxoSmithKline Plc: revenues & profitability

Figure 12: GlaxoSmithKline Plc: assets & liabilities

Figure 13: Novartis AG: revenues & profitability

Figure 14: Novartis AG: assets & liabilities

Figure 15: Pfizer Inc.: revenues & profitability

Figure 16: Pfizer Inc.: assets & liabilities

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports